Thyme Care closed $95M in a Series C round led by Concord Health Partners and Banc of California to fuel cancer care affordability.
Thyme Care closed $95M in a Series C round led by Concord Health Partners and Banc of California to fuel cancer care affordability.
07/16/24, 12:04 PM
Location
nashvilleMoney raised
$95 million
Industry
health care
Round Type
series c
Investors
Banc Of California, Foresite Capital, Frist Cressey Ventures, Echo Health Ventures, Alley Corp, A16z Bio + Health, Town Hall Ventures, Cvs Health Ventures, Concord Health Partners
Thyme Care, the leading value-based cancer care enabler, announced the close of a $95M capital raise, with $55M in equity funding and an additional $40M in debt financing.
Company Info
Location
10 lea avenue, suite 760
nashville, arkansas, united states
Additional Info
Thyme Care is an oncology care management company providing high-touch, technology-enabled care navigation. Founded to create a better cancer journey for all, Thyme Care guides cancer patients and their caregivers through a complex healthcare system by providing personalized resources, support, and quick access to high-value care. The company’s unique approach aligns the incentives of patients, payers and providers and coordinates integrated care that drives value and leads to better outcomes.